Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Quoin Pharmaceuticals ( (QNRX) ) has shared an update.
Quoin Pharmaceuticals Ltd. held its 2024 Annual General Meeting where shareholders approved amendments to the company’s Articles of Association and compensation programs for key executives. These amendments align with Israeli regulations and Nasdaq rules, potentially impacting shareholder meeting protocols and executive compensation structures. The meeting also saw the election of directors, approval of changes to non-employee directors’ compensation, and the appointment of Marcum LLP as the company’s auditor, reflecting strategic governance and financial oversight adjustments.
More about Quoin Pharmaceuticals
YTD Price Performance: -84.10%
Average Trading Volume: 3,002,031
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $3.94M
For a thorough assessment of QNRX stock, go to TipRanks’ Stock Analysis page.
